Dear Cell & Gene readers,
What a year it's been in the cell and gene sector! Throughout 2021, Cell & Gene delivered impactful editorial on R&D, supply chain and logistics, the long, regulated road to commercialization, and everything in between. We launched Cell & Gene: The Podcast featuring some of the sector's best and brightest leaders, and we've continued our Cell & Gene Live webinar series. In 2022 (and beyond), we're excited to continue our mission of bringing you the most timely insight to help you better perform your role.
For your convenience, we’ve compiled a list of this year’s Top 10 most-read “Guest” and “From the Editor” columns, “Industry Insights,” and “Products and Services.” Whether they’re new to you, or to review, be sure to give these articles a read.
From all of us at Cell & Gene, we wish you and yours a safe and healthy 2022.
Erin Harris, editor in chief
Follow me on Twitter